5-1801434-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004553.6(NDUFS6):c.17C>T(p.Thr6Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 1,605,112 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T6T) has been classified as Likely benign.
Frequency
Consequence
NM_004553.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFS6 | NM_004553.6 | c.17C>T | p.Thr6Ile | missense_variant | 1/4 | ENST00000274137.10 | |
MRPL36 | XM_011514080.3 | c.-68G>A | 5_prime_UTR_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFS6 | ENST00000274137.10 | c.17C>T | p.Thr6Ile | missense_variant | 1/4 | 1 | NM_004553.6 | P1 | |
NDUFS6 | ENST00000469176.1 | c.17C>T | p.Thr6Ile | missense_variant | 1/3 | 2 | |||
NDUFS6 | ENST00000510329.1 | n.14C>T | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 36
GnomAD3 exomes AF: 0.0000176 AC: 4AN: 227236Hom.: 0 AF XY: 0.0000238 AC XY: 3AN XY: 126198
GnomAD4 exome AF: 0.0000248 AC: 36AN: 1452854Hom.: 0 Cov.: 33 AF XY: 0.0000249 AC XY: 18AN XY: 722714
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 74398
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.17C>T (p.T6I) alteration is located in exon 1 (coding exon 1) of the NDUFS6 gene. This alteration results from a C to T substitution at nucleotide position 17, causing the threonine (T) at amino acid position 6 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 01, 2022 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 6 of the NDUFS6 protein (p.Thr6Ile). This variant is present in population databases (rs754131778, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with NDUFS6-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at